|
Real-time Estimate
Cboe BZX
05:59:41 03/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 852.20 USD | +3.44% |
|
+4.80% | +10.63% |
| Market Cap | 82.26B 70.97B 66.85B 60.91B 114B 7,771B 115B 791B 307B 3,973B 309B 302B 13,051B | P/E 2026 * |
19.1x | P/E 2027 * | 16.4x |
|---|---|---|---|---|---|
| Enterprise Value | 75.39B 65.04B 61.27B 55.83B 104B 7,122B 105B 725B 282B 3,641B 283B 277B 11,962B | EV / Sales 2026 * |
4.46x | EV / Sales 2027 * | 3.89x |
| Free-Float |
71.06% | Yield 2026 * |
0.47% | Yield 2027 * | 0.54% |
Last Transcript : Regeneron Pharmaceuticals, Inc.
| 1 day | +3.34% | ||
| 1 week | +4.45% | ||
| Current month | +6.50% | ||
| 1 month | +12.09% | ||
| 3 months | +41.15% | ||
| 6 months | +7.61% | ||
| Current year | +10.25% |
| 1 week | 779.08 |  | 852.51 |
| 1 month | 747 | | 852.51 |
| Current year | 591.52 | | 852.51 |
| 1 year | 541 | | 852.51 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 01/01/2001 | |
| Chief Executive Officer | 73 | 08/01/1988 | |
| Director of Finance/CFO | 55 | 05/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 09/06/2023 | |
Michael Brown
BRD | Director/Board Member | 85 | 01/06/1991 |
Joseph Goldstein
BRD | Director/Board Member | 85 | 01/06/1991 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 19/8/26 | Exercice | General Counsel | 33,583 | 0.0326% | ||
| 18/8/26 | Exercice | Chief Financial Officer | 17,165 | 0.0167% | ||
| 10/8/26 | Exercice | Director | 1,200 | 0.0012% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.35% | +4.45% | +47.26% | +3.41% | 82.26B | |
| -2.66% | +0.08% | +519.18% | +36.96% | 61.59B | |
| +0.89% | +0.12% | -17.32% | -35.39% | 59.05B | |
| -1.25% | -5.30% | -1.98% | +33.18% | 51.23B | |
| +0.92% | -0.23% | +11.50% | +169.82% | 48.3B | |
| +3.66% | +1.26% | +60.32% | -15.94% | 31.92B | |
| +2.26% | -0.26% | +48.63% | +101.94% | 25.34B | |
| +0.20% | +1.70% | -3.42% | +190.03% | 22.56B | |
| -0.52% | -1.98% | +65.45% | +110.84% | 16.56B | |
| -0.83% | -2.29% | -14.71% | +786.97% | 15.28B | |
| Average | +0.59% | -2.66% | +71.49% | +138.18% | 41.41B | |
| Weighted average by Cap. | +0.72% | -2.82% | +94.75% | +73.87% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.92B 14.6B 13.75B 12.53B 23.42B 1,598B 23.59B 163B 63.18B 817B 63.54B 62.15B 2,685B | 18.42B 15.89B 14.97B 13.64B 25.49B 1,740B 25.68B 177B 68.77B 890B 69.16B 67.65B 2,922B |
| Net income | 4.77B 4.12B 3.88B 3.53B 6.61B 451B 6.66B 45.93B 17.82B 231B 17.92B 17.53B 757B | 5.45B 4.7B 4.43B 4.03B 7.54B 514B 7.59B 52.39B 20.33B 263B 20.45B 20B 864B |
| Net Debt | -6.87B -5.93B -5.58B -5.09B -9.51B -649B -9.58B -66.08B -25.65B -332B -25.79B -25.23B -1,090B | -10.55B -9.1B -8.58B -7.81B -14.61B -997B -14.72B -102B -39.41B -510B -39.63B -38.76B -1,674B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/09/26 | USD 853.70 | +3.63% | 481,231 |
| 01/09/26 | USD 823.82 | +3.10% | 682,806 |
| 31/08/26 | USD 799.08 | +0.62% | 894,268 |
| 28/08/26 | USD 794.19 | -1.67% | 488,305 |
| 27/08/26 | USD 807.71 | -0.87% | 766,990 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
Select your edition
All financial news and data tailored to specific country editions
